rs144413438
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_000395.3(CSF2RB):c.2431G>A(p.Glu811Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000115 in 1,614,016 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_000395.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CSF2RB | NM_000395.3 | c.2431G>A | p.Glu811Lys | missense_variant | 14/14 | ENST00000403662.8 | NP_000386.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CSF2RB | ENST00000403662.8 | c.2431G>A | p.Glu811Lys | missense_variant | 14/14 | 5 | NM_000395.3 | ENSP00000384053.3 | ||
CSF2RB | ENST00000406230.5 | c.2449G>A | p.Glu817Lys | missense_variant | 13/13 | 1 | ENSP00000385271.1 |
Frequencies
GnomAD3 genomes AF: 0.000125 AC: 19AN: 152170Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000994 AC: 25AN: 251392Hom.: 0 AF XY: 0.000118 AC XY: 16AN XY: 135870
GnomAD4 exome AF: 0.000114 AC: 167AN: 1461846Hom.: 1 Cov.: 35 AF XY: 0.000105 AC XY: 76AN XY: 727220
GnomAD4 genome AF: 0.000125 AC: 19AN: 152170Hom.: 0 Cov.: 32 AF XY: 0.000148 AC XY: 11AN XY: 74346
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Apr 10, 2017 | Variant classified as Uncertain Significance - Favor Benign. The p.Glu811Lys var iant in CSF2RB has not been previously reported in individuals with pulmonary di sease, but has been identified in 8/66686 European chromosomes by the Exome Aggr egation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs144413438). Gl utamic acid (Glu) at position 811 is not conserved in mammals or evolutionarily distant species and 2 mammals (rabbit and elephant) carry a lysine (Lys) at this position, raising the possibility that this change may be tolerated. In summary , while the clinical significance of the p.Glu811Lys variant is uncertain, these data suggest that it is more likely to be benign. - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 27, 2024 | The c.2431G>A (p.E811K) alteration is located in exon 14 (coding exon 13) of the CSF2RB gene. This alteration results from a G to A substitution at nucleotide position 2431, causing the glutamic acid (E) at amino acid position 811 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 26, 2024 | This sequence change replaces glutamic acid, which is acidic and polar, with lysine, which is basic and polar, at codon 811 of the CSF2RB protein (p.Glu811Lys). This variant is present in population databases (rs144413438, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with CSF2RB-related conditions. ClinVar contains an entry for this variant (Variation ID: 504875). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt CSF2RB protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at